Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration and has been prescribed to patients in the United States.
Financial Statements
- Click here to download Incyte Corp.'s Income Statement
- Click here to download Incyte Corp.'s Balance Sheet
- Click here to download Incyte Corp.'s Statement of Cash Flows
Key Info
- Industry:
- Sector:
- CEO Name: Paul Friedman
Key Statistics
- Stock Price: $85.42
- Dividend Yield: 0%
- Market Capitalization: $18,706,646,008
- Shares Outstanding: 218,996,090
- Number of Employees: 1,456
- Trailing 12-Month EPS: $-0.88
- Trailing 12-Month DPS: $0
- Payout Ratio: -0.0%
Important Dates
- Next Earnings Date:
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $85.42
- 52-week high: $109.69
- 52-week low: $63.18
- 200-day moving average: $94.07
- 50-day moving average: $85.6
Performance
- 1-Month Price Return: -1.4%
- 3-Month Price Return: -8.1%
- 6-Month Price Return: -16.0%
- 1-Year Price Return: -9.3%
- 2-Year Price Return: 32.9%
- 5-Year Price Return: -23.9%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
December 2nd, 2020